Respiratory Syncytial Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: A Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Infants and Children Aged 28 Days to 36 Months Infected With Respiratory Syncytial Virus [Phase 2]
Phase 2 trial evaluating lumicitabine (JNJ-64041575) in hospitalized infants and children with respiratory syncytial virus; study terminated…